Circulation publishes Benestent II pilot results
This article was originally published in Clinica
Heparin-coated stents are 99% effective in opening coronary arteries without clotting complications, according to results from the Benestent II pilot study published in the American Heart Association journal Circulation, this month. Stent thrombosis was 3.5% in Benestent I, the trial of the uncoated Palmaz-Schatz stent. The pilot study results, were first presented at the European Society of Cardiology meeting in Amsterdam in August 1995 (see Clinica No 669/70, p 24).
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.